EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mineralocorticoid blockade mitigates aortic aneurysms in mice underexpressing transforming growth factor-β1

Masao Kakoki, John R Hagaman, Masahiko Terajima, Mitsuo Yamauchi, Kenji Kansaku

The Journal of Physiological Sciences · 2026-11 · 76 (3) · 100116

DOI: 10.1016/j.jphyss.2026.100116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiological Sciences, 2026-11. Verfasst von Masao Kakoki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga district, Tochigi 321-0293, Japan. Electronic address: m-kak…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss-of-function mutations in the component genes of transforming growth factor (TGF)-β signaling have been demonstrated to cause proximal aortic aneurysms in humans (Loeys-Dietz Syndrome). Recently, we have demonstrated that homozygous mice for the loss-of-function mutation in the Tgfb1 gene (Tgfb1L/L mice) develop proximal aortic aneurysms which is associated with elevated plasma aldosterone levels. Here we found that chronic oral administration of a mineralocorticoid receptor antagonist eplerenone substantially prevented aortic aneurysms and elongated lifespans in Tgfb1L/L mice. Amiloride, which caused depressor effects comparative to eplerenone, resulted in less protection against aneurysms and early deaths than eplerenone in Tgfb1L/L mice. The reduced aortic levels of pyridinoline and (iso)desmosine which are collagen and elastin stable crosslinks, and of the expression of their associated enzymes in Tgfb1L/L mice were significantly restored by the eplerenone administration. These results suggest that mineralocorticoid receptor blockade is useful to prevent aortic aneurysms and early deaths in Loeys-Dietz Syndrome.

Schlagwörter

Stichwörter der Autor:innen

3’ untranslated regionExtracellular matrixGene titration

Autor:innen und Institutionen

  • Department of Physiology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga district, Tochigi 321-0293, Japan. Electronic address: m-kakoki@dokkyomed.ac.jp.
  • Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
  • Department of Dentistry, Asahi University, 1851 Hozumi, Gifu, Mizuho 501-0296, Japan.
  • Division of Oral and Craniofacial Health Sciences, Adams School of Dentistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, United States.
  • Department of Physiology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga district, Tochigi 321-0293, Japan.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Kakoki, M., Hagaman, J. R., Terajima, M., Yamauchi, M., & Kansaku, K. (2026). Mineralocorticoid blockade mitigates aortic aneurysms in mice underexpressing transforming growth factor-β1. The Journal of Physiological Sciences, 76(3), 100116. https://doi.org/10.1016/j.jphyss.2026.100116

Vancouver

Kakoki M, Hagaman JR, Terajima M, Yamauchi M, Kansaku K. Mineralocorticoid blockade mitigates aortic aneurysms in mice underexpressing transforming growth factor-β1. The Journal of Physiological Sciences. 2026;76(3):100116. doi:10.1016/j.jphyss.2026.100116

BibTeX
@article{Kakoki2026,
  author = {Kakoki, Masao and Hagaman, John R and Terajima, Masahiko and Yamauchi, Mitsuo and Kansaku, Kenji},
  title = {Mineralocorticoid blockade mitigates aortic aneurysms in mice underexpressing transforming growth factor-β1},
  journal = {The Journal of Physiological Sciences},
  year = {2026},
  volume = {76},
  number = {3},
  pages = {100116},
  doi = {10.1016/j.jphyss.2026.100116}
}
Kostenlos starten →